213 related articles for article (PubMed ID: 27228307)
1. Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson's Disease.
Han BS; Kim KS; Kim YJ; Jung HY; Kang YM; Lee KS; Sohn MJ; Kim CH; Kim KS; Kim WG
J Nat Prod; 2016 Jun; 79(6):1604-9. PubMed ID: 27228307
[TBL] [Abstract][Full Text] [Related]
2. Daphnane and Phorbol Diterpenes, Anti-neuroinflammatory Compounds with Nurr1 Activation from the Roots and Stems of Daphne genkwa.
Han BS; Minh NV; Choi HY; Byun JS; Kim WG
Biol Pharm Bull; 2017; 40(12):2205-2211. PubMed ID: 29199243
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
Kim CH; Han BS; Moon J; Kim DJ; Shin J; Rajan S; Nguyen QT; Sohn M; Kim WG; Han M; Jeong I; Kim KS; Lee EH; Tu Y; Naffin-Olivos JL; Park CH; Ringe D; Yoon HS; Petsko GA; Kim KS
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8756-61. PubMed ID: 26124091
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
Hedya SA; Safar MM; Bahgat AK
Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.
Hammond SL; Safe S; Tjalkens RB
Neurosci Lett; 2015 Oct; 607():83-89. PubMed ID: 26383113
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
7. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
8. Lethal Factor Domain-Mediated Delivery of Nurr1 Transcription Factor Enhances Tyrosine Hydroxylase Activity and Protects from Neurotoxin-Induced Degeneration of Dopaminergic Cells.
Paliga D; Raudzus F; Leppla SH; Heumann R; Neumann S
Mol Neurobiol; 2019 May; 56(5):3393-3403. PubMed ID: 30121937
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1141-1150. PubMed ID: 31408200
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
11. Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment.
Wei X; Gao H; Zou J; Liu X; Chen D; Liao J; Xu Y; Ma L; Tang B; Zhang Z; Cai X; Jin K; Xia Y; Wang Q
Mol Neurobiol; 2016 Nov; 53(9):5876-5892. PubMed ID: 26497037
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway.
Gao H; Wang D; Wang YL; Mao JP; Jiang S; Yang XL
Mol Biol Rep; 2021 Apr; 48(4):3079-3087. PubMed ID: 33891271
[TBL] [Abstract][Full Text] [Related]
13. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
[TBL] [Abstract][Full Text] [Related]
14. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
Lei Z; Jiang Y; Li T; Zhu J; Zeng S
J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
[TBL] [Abstract][Full Text] [Related]
15. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
Kambey PA; Chengcheng M; Xiaoxiao G; Abdulrahman AA; Kanwore K; Nadeem I; Jiao W; Gao D
Metab Brain Dis; 2021 Apr; 36(4):609-625. PubMed ID: 33507465
[TBL] [Abstract][Full Text] [Related]
16. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
17. Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
Spathis AD; Asvos X; Ziavra D; Karampelas T; Topouzis S; Cournia Z; Qing X; Alexakos P; Smits LM; Dalla C; Rideout HJ; Schwamborn JC; Tamvakopoulos C; Fokas D; Vassilatis DK
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3999-4004. PubMed ID: 28348207
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF
Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
